Parkinson's Disease

Parkinson's Now a Hot Therapeutic Area: What's Up Lately?
Parkinson's Now a Hot Therapeutic Area: What's Up Lately?
Yahoo/Zacks.com
Parkinson's Disease
Novartis
Teva Pharmaceutial
UCB Pharma
MEDI1341
AstraZeneca
Takeda
PRX002
Prothena
Roche
Acorda
Inbrija
Adamas Pharmaceuticals
Gocovri
Flag link:
AstraZeneca auctions off rights to another pipeline drug as Takeda grabs $400M Parkinson’s deal
AstraZeneca auctions off rights to another pipeline drug as Takeda grabs $400M Parkinson’s deal
Endpoints
AstraZeneca
Takeda
MEDI1341
Parkinson's Disease
Flag link:
FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
Xconomy
FDA
Acorda Therapeutics
Parkinson's Disease
Inbrija
Flag link:
Adamas Parkinson's drug gains FDA approval
Adamas Parkinson's drug gains FDA approval
Biopharma Dive
Adamas Pharmaceuticals
Parkinson's Disease
FDA
Gocovri
Flag link:
Titan wins FDA nod to study Parkinson’s implant
Titan wins FDA nod to study Parkinson’s implant
Drug Delivery Business News
Titan Pharmaceuticals
Parkinson's Disease
ropinirole
Flag link:
Parkinson's drug Xadago launches in US
Parkinson's drug Xadago launches in US
BioPharma Dive
Parkinson's Disease
Xadago
drug launches
Flag link:
Acorda plans NDA for inhaled Parkinson’s drug after touting long-term safety data
Acorda plans NDA for inhaled Parkinson’s drug after touting long-term safety data
Mass Device
Acorda Therapeutics
Parkinson's Disease
CVT-301
Levodopa
Flag link:
After an odyssey of setbacks, FDA finally green-lights Newron’s Parkinson’s drug Xadago
After an odyssey of setbacks, FDA finally green-lights Newron’s Parkinson’s drug Xadago
Endpoints
FDA
Newron Pharma
Parkinson's Disease
Xadago
safinamide
Flag link:
Neurocrine adds a Parkinson’s drug to its late-stage pipeline in $145M deal
Neurocrine adds a Parkinson’s drug to its late-stage pipeline in $145M deal
Endpoints
Neurocrine
Parkinson's Disease
Ongentys
Bial
Flag link:
Acorda stock surges 9% after positive late-stage clinical trial results for Parkinson's drug
Acorda stock surges 9% after positive late-stage clinical trial results for Parkinson's drug
Marketwatch
Acorda Therapeutics
clinical trials
CVT-301
Parkinson's Disease
Flag link:
Cancer drug could benefit Parkinson's patients, study shows
Cancer drug could benefit Parkinson's patients, study shows
BioPharma Dive
Parkinson's Disease
Novartis
Tasigna
Flag link:
Pfizer And IBM Launch Ambitious 'Internet Of Things' For Parkinson's Research
Pfizer And IBM Launch Ambitious 'Internet Of Things' For Parkinson's Research
Forbes
Pfizer
IBM
Parkinson's Disease
wearables
devices
Internet of Things
R&D
Flag link:
Newron faces further FDA delay for Parkinson's drug as regulator demands addiction evidence
Newron faces further FDA delay for Parkinson's drug as regulator demands addiction evidence
Fierce Biotech
Newron Pharma
FDA
Parkinson's Disease
Xadago
Flag link:
7 big pharma companies sign on to Parkinson's development group
7 big pharma companies sign on to Parkinson's development group
BioPharma Dive
R&D
AbbVie
AstraZeneca
Biogen
Eli Lilly
Merck
Pfizer
UCB Pharma
Parkinson's Disease
Flag link:
FDA Approves Medtronic Deep Brain Stimulation for People with Parkinson's Disease with Recent Onset of Motor Complications
FDA Approves Medtronic Deep Brain Stimulation for People with Parkinson's Disease with Recent Onset of Motor Complications
Yahoo
Medtronic
deep brain stimulation
FDA
Parkinson's Disease
Flag link:
Fidelity, Biogen, Sanofi Join $45M Bet On Alzheimer's And Parkinson's Startup
Fidelity, Biogen, Sanofi Join $45M Bet On Alzheimer's And Parkinson's Startup
Forbes
Biogen
Sanofi
Alzheimer's disease
Parkinson's Disease
Yumanity Therapeutics
Flag link:
Acorda bags PhIII Parkinson's drug in $363M Biotie buyout
Acorda bags PhIII Parkinson's drug in $363M Biotie buyout
Fierce Biotech
Acorda Therapeutics
Parkinson's Disease
BioTie Therapies
M&A
tozadenant
Flag link:
Novartis Cancer Drug Shows Promise as Treatment for Parkinson's
Novartis Cancer Drug Shows Promise as Treatment for Parkinson's
Bloomberg
Tasigna
Novartis
Parkinson's Disease
Flag link:
Google Reveals Gigantic Ambitions To Fight Cancer, Diabetes, Parkinson's, Heart Problems
Google Reveals Gigantic Ambitions To Fight Cancer, Diabetes, Parkinson's, Heart Problems
Forbes
Google
Alphabet
diabetes
Parkinson's Disease
cancer
heart disease
Flag link:
3 Long Shots Biotech Companies Are Working On
3 Long Shots Biotech Companies Are Working On
Motley Fool
biotech
Alzheimer's disease
Parkinson's Disease
Axovant Sciences
RVT 101
GSK
Biogen
aducanumab
Prothena
PRX-002
Flag link: